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INTRODUCTION
Cat scratch disease (CSD) is a worldwide zoonosis caused
by Bartonella henselae or possibly by Bartonella clarridgeiae (1-
3). It is characterized usually a self-limiting regional lym-
phadenopathy, associated with a cat scratch or bite. Originally
considered rare, it is now recognized as a common cause of
lymphadenopathy in children and young adults (2). Classic
systemic disease includes a cutaneous inoculation by a scratch
or bite followed by a regional lymphadenopathy after a vari-
able period, ranging from 1 to 8 weeks. The number of pet
cats is increasing in developed countries including Korea.
According to the increase in number of pet cats, zoonosis
like CSD has risen as a health problem in human society. In
the past most cases of CSD were diagnosed by clinical man-
ifestations and intradermal reaction with specimens taken
from patients before isolation of the causative organisms. Due
to the difficulty of isolation of B. henselae from CSD patient,
the diagnosis is usually based on serologic data and clinical
history when informative. Recently polymerase chain reac-
tion (PCR) is used as a confirmative method with biopsy or
aspiration specimen of lymph nodes from CSD patients (4-6).
In Korea, there is no reported case of CSD confirmed by PCR.
This report deals with a case of CSD confirmed by PCR assay
using different sets of primers.
CASE REPORT 
A 25-yr-old previously healthy woman visited Sanggye-
paik Hospital with high fever over 7 days and painful mass
in the left neck. In spite of medication of oral antibiotics at
a private clinic, her symptoms were not improved. She had
been admitted to our hospital on 7 May 2004. She had been
keeping a dog for 4 months before admission but had no his-
tory of contact with a cat. 
On admission there were multiple palpable mass in the left
neck area. The masses were 2 cm and 1.5 cm in diameter, and
were tender. On physical examination liver and spleen was not
palpable. There was no skin lesion or scratched wound in the
face, extremity and trunk. 
She had a white cell count of 3,490×109/L (neutrophil, 87
%; lymphocyte, 8.6%; monocyte, 3.2%), with platelets 100×
109/L, a hemoglobin of 12.1 g/dL. Blood chemistry revealed:
AST 71 IU/L, ALT 62 IU/L, total bilirubin 0.3 mg/dL, BUN
8 mg/dL, creatinine 0.7 mg/dL. Laboratory findings showed
elevated CRP, but ESR was 3 mm/hr. ANA and anti-dS DNA
was negative. The computed tomography of the patient’s neck
showed multiple variable-sized lymph nodes (maximum 16
×10 mm). The serum sample from the patient was tested
for B. henselae antibodies by using a commercial immunoflu-
orescent assay (Bartonella IFA IgG; Focus technologies, Cy-
press, CA, U.S.A.). The IgG titer was 1:64 positive. Aspira-
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Detection of Bartonella henselae DNA by Polymerase Chain Reaction
in a Patient with Cat Scratch Disease
: A Case Report
We report a case of cat scratch disease caused by Bartonella henselae in Korea.
A 25-yr-old woman developed left cervical lymphadenopathy with history of contact
with a dog. The cervical lymphadenopathy persisted for 1 month and resolved grad-
ually and spontaneously. Serologic test was not done during the acute stage of the
disease. Immunofluorescent antibody test performed during the convalescent stage
was positive for B. henselae. To confirm B. henselae infection, polymerase chain
reaction (PCR) analysis using aspirates of cervical lymph node was performed and
the presence of B. henselae DNA was demonstrated. This is the first reported case
of cat scratch disease in Korea confirmed by PCR for B. henselae DNA .
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tion cytology of lymph node of left neck revealed reactive hy-
perplasia. 
The patient started receiving clindamycin intravenously for
6 days after lymph node aspiration. The fever and pain in the
left neck area persisted during the treatment. Under the im-
pression of reactive lymphadenitis she had been discharged
without medication. During the outpatient clinic follow up
her symptoms improved gradually without medication and
completely recovered one month later. She had remained asy-
mptomatic for 3 months.
The detection of B. henselae DNA from lymph node aspi-
rate using PCR
To prepare template DNA from the lymph node aspirate,
QIAamp DNA Tissue Mini Kit (QIAGEN GmbH, Hilden,
Germany) was used. B. henselae Huston-1 (ATCC 49882) DNA
was used for positive control. We selected the primer sets (TN-
1, TN-2, and IP) for the gltA gene used by Margolis et al. (5)
and the primer sets (PAPn1, PAPn2, and PAPns2) for the pap
31 gene used by Zeaiter et al. (6). Seminested PCR protocols
for amplification of the B. henselae gltA and pap31 genes were
applied to the sample (Table 1). The size of the amplified DNA
fragments was 139 bp and 211 bp for the gltA and pap31 ge-
nes respectively (6, 14). B. henselae DNA was detected from
patient’s lymph node aspirate (Fig. 1). PCR products were
sequenced. For gltA gene, IP and TN-1 were used (5) and for
pap31, PAPns2 and PAPns1 were used (6). They were se-
quenced at both directions with BigDye Terminator v3.1 Cy-
cle Sequencing kit (Applied Biosystems, Foster, CA, U.S.A.).
Sequencing products were resolved with ABI 3,730 XL auto-
analyzer (Applied Biosystems, Foster, CA, U.S.A.). The se-
quences were aligned with the gltA or pap31 sequences avail-
able in GenBank for B. henselae isolates. The patient’s PCR
product for gltA had a consistent sequence of B. henselae and
*: Primer positions are numbered to the gene of B. henselae (strain Hous-
ton-1). 
Primer
PAPn1 pap31 TTCTAGGAGTTGAAACCGAT 438-457 (    )
PAPn2 pap31 GAAACACCACCAGCAACATA 695-714 (    )
PAPns2 pap31 GCACCAGACCATTTTTCCTT 629-648 (    )
TN-2 gltA TGGTGGAGCTAATGAAGCATG 796-814 (    )
TN-1 gltA CCTCATGGCAGGTTTGTTGC 957-976 (    )
IP gltA GTTCTGTTGAAAGAATTCCTGA 838-860 (    )
Table 1. Oligonucleotide primers used for polymerase chain reac-
tion and sequencing 
Target
gene
Position
(direction)*
Nucleotide sequence
12 3456 7 8
gltA gene pap31 gene
Fig. 1. Results of seminested polymerase chain reaction (PCR) for
gltA gene and pap 31 gene of B. henselae. Lanes 2-4 for PCR of
gltA gene (139 bp), lane 6-8 for PCR of pap31 gene (211 bp). Lane
1 and 5, DNA ladder marker (Bioneer, Daejeon, Korea); lane 2 and
6 positive control (Houston-1, ATCC 49882); lane 3 and 7, nega-
tive control; lane 4 and 8, lymph node tissue from the patient with
cat scratch disease.
500                    510                    520                
Patient1
AGAGAAGACGCAAAAACCTCTTCTGCTGAAGCTATTGGACAGGATGAACTTGAA 
B. henselae (Houston)              CTTCTGCTGAAGCTATTGGACAGGATGAACTTGAA 
B. henselae (Marseille)             CTTCTGCTAAAGTTATTAGAGAGGATGAACTTGTA
*           *            *      *                                         *
530                   540                     560                  570                  580                  590
ACATTTAGGGATTCCCTTAAAAAAGCTAATGCTGCTTTTGCTCAAGGTAAAACAAGT
ACATTTAGGGATTCCCTTAAAAAAGCTAATGCTGCTTTTGCTCAAGGTAAAACAAGT
AACTTTAAGGATTCCCTTAAAAACGCTAATGCTGTTTTCGCTAAAGATAAAACAATG
*                *                                             *                                   *          *             *            *                          **
600                   610                    620                   630
GATAATGTCGCGGCAGTGGATAAGCATACAGATAGTTTAGCTTTAAAGGAAAAATGG 
GATAATGTCGCGGCAGTGGATAAGCATACAGATAGTTTAGCTTTA
GATGATGTCAAGCAAGATGAAAAGCATACAGATAGTTTAGCTTTA
*                   **       *      **          *
Fig. 2. Partial pap31 sequences of two main genogroups B. henselae and case (red color-primer, blue color-different sequence between
genogroups).890 J.Y. Chung, T.H. Han, B.N. Kim, et al.
for pap31 gene showed a consistent sequence corresponding
to main genogroup of B. henselae Houston (Fig. 2). 
DISCUSSION
CSD, caused by Bartonella henselae, is a worldwide zoonosis
associated with a variety of clinical manifestations. Typically,
a nontender papule develops in the scratch line, three to 10
days after exposure, healing without scarring in two or three
weeks. Regional lymphadenopathy follows in more than 80%
of cases, but resolves usually within two to three months (7).
Atypical CSD are reported up to 25% of cases (8). The man-
ifestations of atypical CSD are fever of unknown origin, neu-
roretinitis, encephalopathy, hepatosplenic granuloma, juvenile
rheumatoid arthritis. Nowadays, B. henselae infection is regard-
ed as a common cause among patients with fever of unknown
origin (9). Atypical presentations are considered as manifes-
tations of Bartonella infection rather than CSD. The epidemi-
ological and clinical characteristics of CSD have been well
delineated in countries other than Korea (2, 8). Epidemiolog-
ical and clinical study of CSD in Korea is rare (10). Domestic
cats or dogs are the reservoirs for B. henselae and it is transmit-
ted through scratches or bites (7, 11, 12). However, no history
of animal contact can be elicited in small percentage of CSD
patient.
Cat scratch disease is usually a self-limiting disease and does
not require therapy. But, some patients with multi-system
involvement may benefit from antibiotics treatment, so it is
necessary to identify the organism rapidly by clinical laborato-
ry assay. The diagnosis of CSD is made currently on the basis
of clinical criteria in addition to a recent history of cat or dog
exposure, a scratch or a flea bite plus bacteria culture, histo-
logic examination of tissue biopsies and serologic test. Al-
though serologic analysis by immunofluorescence or enzyme
linked immnuosorbent assay is a useful tool for the diagno-
sis of B. henselae infection, the specificity of serological assay
has been questioned due to the cross reactivity between B.
henselae and other species (13). Also antigenic variability
within the species could partly explain inconsistent results
in the serological diagnosis of CSD. 
PCR assays appear to be very useful in confirming clinically
suspected CSD and have advantage of rapid diagnosis with
the reliability since it is independent on the patient’s humoral
response. Recent studies relied on PCR amplification to im-
prove diagnosis of CSD (4-6, 14). Earlier assays targeted am-
plification of 16S rRNA gene which is present in all bacteria
with species polymorphism (14). PCR assay using the ampli-
fication of a portion of the citrate synthase gene (gltA) followed
by TaqI restriction digest of the products is a sensitive tool for
the detection of B. henselae DNA in tissue biopsy specimens
and pus aspirates from lymph nodes of patients with CSD, but
require large amounts of clinical material. The pap 31 gene
encodes a major protein associated with a phage from B. hense-
lae and allowed the classification of its strains into two clus-
ters, B. henselae Houston-1 and B. henselae Marseille (6). Avi-
dor et al. (14) demonstrated that PCR diagnosis of CSD from
fine needle aspiration and primary lesion specimens can be
minimally invasive and highly accurate, so precluding the
necessity for excision biopsy. In this case, antibody titer to B.
henselae was positive (1:64) and corresponding sequence to
major genogroup B. henselae Houston was detected by PCR
analysis of lymph node tissue by fine needle aspiration. PCR
offers a rapid and specific means to detect the organism direct-
ly from clinical specimens in CSD patients. And it is more
sensitive than isolation when performed on suitable clinical
samples such as fresh or frozen lymph node tissues. 
In conclusion, when presented with lymphadenopathy, phy-
sicians should inquire about recent cat, dog, or pets contact
and/or animal scratches considering the possibility of CSD.
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